The percentage of CD3+CD4+ T cells expressing PD-1 exhibited a significant 2-fold increase in the severe COVID-19 group compared to the mild disease group (P = 0.0416) (Figure 2H). This evidence concerns the gene PDCD1 and COVID-19.